Post - Marketing Surveillance of the Safety, Tolerability and Efficacy of Vytorin (Ezetimibe + Simvastatin) Tablet Among Filipino Patients

Trial Profile

Post - Marketing Surveillance of the Safety, Tolerability and Efficacy of Vytorin (Ezetimibe + Simvastatin) Tablet Among Filipino Patients

Completed
Phase of Trial: Phase IV

Latest Information Update: 02 Jul 2014

At a glance

  • Drugs Ezetimibe/simvastatin (Primary)
  • Indications Hypercholesterolaemia
  • Focus Adverse reactions
  • Sponsors Merck Sharp & Dohme; Schering-Plough
  • Most Recent Events

    • 05 Jun 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top